Case 3
Samantha Eisman(Sinclair Dermatology), Catherine H. Orteu(Royal Free London NHS Foundation Trust), A Mehta(The Royal Free Hospital)
Cited by 0
Related Papers
European Dermatology Forum S1‐guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes
|Journal of the European Academy of Dermatology and Venereology|2017|262
Interferon‐β mediates stromal cell rescue of T cells from apoptosis
|European Journal of Immunology|1999|199
Fabry disease and the skin: data from FOS, the Fabry outcome survey
|British Journal of Dermatology|2007|178
A deficiency in the in vivo clearance of apoptotic cells is a feature of the NOD mouse
|Journal of Autoimmunity|2006|115
European dermatology forum S1‐guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxedema, scleredema and nephrogenic systemic fibrosis
|Journal of the European Academy of Dermatology and Venereology|2017|115